123 related articles for article (PubMed ID: 12054695)
1. Identification of oxidized plasma proteins in Alzheimer's disease.
Choi J; Malakowsky CA; Talent JM; Conrad CC; Gracy RW
Biochem Biophys Res Commun; 2002 May; 293(5):1566-70. PubMed ID: 12054695
[TBL] [Abstract][Full Text] [Related]
2. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
[TBL] [Abstract][Full Text] [Related]
3. Oxidized proteins in Alzheimer's plasma.
Conrad CC; Marshall PL; Talent JM; Malakowsky CA; Choi J; Gracy RW
Biochem Biophys Res Commun; 2000 Aug; 275(2):678-81. PubMed ID: 10964722
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma.
Tezel G; Yang X; Cai J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3177-87. PubMed ID: 16123417
[TBL] [Abstract][Full Text] [Related]
5. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
6. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of protein oxidation in Alzheimer's disease brain.
Korolainen MA; Goldsteins G; Alafuzoff I; Koistinaho J; Pirttilä T
Electrophoresis; 2002 Sep; 23(19):3428-33. PubMed ID: 12373773
[TBL] [Abstract][Full Text] [Related]
8. Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry.
Davidsson P; Folkesson S; Christiansson M; Lindbjer M; Dellheden B; Blennow K; Westman-Brinkmalm A
Rapid Commun Mass Spectrom; 2002; 16(22):2083-8. PubMed ID: 12415540
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
[TBL] [Abstract][Full Text] [Related]
10. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease.
Yoo BC; Kim SH; Cairns N; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2001 Jan; 280(1):249-58. PubMed ID: 11162507
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
[TBL] [Abstract][Full Text] [Related]
12. Proteome studies of CSF in AD patients.
Davidsson P; Sjögren M
Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease.
Perez-Gracia E; Blanco R; Carmona M; Carro E; Ferrer I
Acta Neuropathol; 2009 Oct; 118(4):497-504. PubMed ID: 19597827
[TBL] [Abstract][Full Text] [Related]
14. Noncovalent interactions in human plasma proteins analyzed by the comparison of nondenaturing and denaturing micro-2-D gel electrophoresis patterns after polypeptide assignment using matrix-assisted laser desorption/ionization-mass spectrometry and peptide mass fingerprinting.
Manabe T; Jin Y
Electrophoresis; 2008 Jun; 29(12):2672-88. PubMed ID: 18494033
[TBL] [Abstract][Full Text] [Related]
15. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease.
Choi J; Forster MJ; McDonald SR; Weintraub ST; Carroll CA; Gracy RW
Free Radic Biol Med; 2004 May; 36(9):1155-62. PubMed ID: 15082069
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry.
Stübiger G; Marchetti M; Nagano M; Reichel C; Gmeiner G; Allmaier G
Rapid Commun Mass Spectrom; 2005; 19(5):728-42. PubMed ID: 15700237
[TBL] [Abstract][Full Text] [Related]
19. Crosslinking of human lens 9 kDa gammaD-crystallin fragment in vitro and in vivo.
Srivastava OP; Srivastava K
Mol Vis; 2003 Dec; 9():644-56. PubMed ID: 14685148
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis.
Sizova D; Charbaut E; Delalande F; Poirier F; High AA; Parker F; Van Dorsselaer A; Duchesne M; Diu-Hercend A
Neurobiol Aging; 2007 Mar; 28(3):357-70. PubMed ID: 16519965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
